Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Richard Drachtman

 Interim Director, Pediatric Hematology Oncology,  Rutgers Cancer Institute of New Jersey, USA 

Biography

 Richard Drachtman, MD, interim chief of pediatric hematology/oncology at Rutgers Cancer Institute of New Jersey has been appointed as Vice Chair of the National Cancer Institute (NCI) Pediatric Central Institutional Review Board (PedCIRB). Dr. Drachtman, who also is a professor of pediatrics at Rutgers Robert Wood Johnson Medical School, was selected based on his experience as an NCI PedCIRB member – having served on the panel since 2009.  He also was selected based on his knowledge of current clinical oncology practice and experience working with NCI Cooperative Groups.

Research Interest

  Hematology, Cancer Therapy,  Sickle cell disease

 

Publications
Top